Kalderos
Venture Round in 2022
Kalderos, Inc. is a company that specializes in drug discount management solutions for various stakeholders in the U.S. healthcare system, including providers, manufacturers, and payers. Established in 2016 and headquartered in Chicago, Illinois, with an additional location in Brookfield, Wisconsin, Kalderos offers a software-as-a-service (SaaS) platform designed to analyze and streamline the complex coordination of drug discount programs. The platform employs advanced models and machine learning to identify and resolve non-compliance issues, detecting inconsistencies that traditional methods often miss. By providing data management capabilities and customizable insights, Kalderos enables clients to enhance their processes for claims verification, dispute resolution, and discount monitoring, ultimately reducing waste and improving operational efficiency.
Lumanu, Inc. is a digital marketing platform that facilitates connections between companies and brand ambassadors, primarily serving brand marketers, performance marketers, agency marketers, and creators. Founded in 2016 and based in Oakland, California, with an additional office in Milwaukee, the company offers a range of solutions including SocialCert, which enables influencers to share content and usage rights with marketers; Content Manager, which helps in content ingestion from influencers; and SmartBoost, which generates advertisements using influencer-created content. In addition to its marketing solutions, Lumanu provides financial management tools that simplify payment processes and compliance for creators and freelancers, enabling them to efficiently manage their business operations while fostering a supportive community.
Leo Cancer Care
Series B in 2021
Leo Cancer Care is focused on revolutionizing cancer radiation therapy by offering a treatment system designed to enhance patient experience and outcomes. Founded in Australia, the company leverages global research that highlights the benefits of upright patient positioning during treatment. This innovative approach shifts the traditional paradigm of machine rotation to patient rotation, allowing for a more controlled and efficient therapy process. The system integrates advanced 3D imaging and precise radiation beam management, ensuring that the appropriate amount of energy is delivered to targeted tissues. By streamlining cancer treatment and connecting patients to centralized care centers, Leo Cancer Care aims to reduce both the physical discomfort and costs typically associated with chemotherapy and radiation therapy, ultimately putting patients in control of their treatment journey.
Cultured Decadence
Seed Round in 2020
Cultured Decadence is a startup based in Madison, Wisconsin, focused on cellular aquaculture to produce crustacean products. Founded in 2020, the company employs innovative cell culture and tissue engineering techniques to create lobster and crab meat directly from the animals' cells, eliminating shell, organs, and waste. This approach addresses the increasing global demand for sustainable and nutritious seafood, offering a more environmentally friendly alternative to traditional fishing methods.
Asto CT
Venture Round in 2019
Asto CT LLC specializes in developing advanced X-ray computed tomography (CT) systems aimed at enhancing equine healthcare. Founded in 2015 and based in Madison, Wisconsin, the company focuses on preventing fractures and improving the overall well-being of thoroughbreds, show horses, recreational horses, and older equines. Asto CT's technology enhances fracture risk detection, facilitates the diagnosis of lameness, and aids in the management of dental and sinus conditions. Their flagship product, Equina, delivers rapid 3D imaging of the lower limbs, head, and neck of standing horses without the need for general anesthesia, ensuring a safer and more comfortable experience for the animals. By integrating cutting-edge robotics with fan-beam CT technology, Asto CT is committed to providing high-quality diagnostic imaging that supports veterinarians in delivering effective treatments.
Somna Therapeutics
Venture Round in 2018
Somna Therapeutics, established in 2012 in Germantown, Wisconsin, specializes in medical devices for treating laryngopharyngeal and extraesophageal acid reflux diseases. Its flagship product, the Reza Band, is a non-pharmacological, investigational device designed to prevent reflux into the larynx, pharynx, and lungs. The company, founded in partnership with the Medical College of Wisconsin, aims to enhance the quality of life for LPR and EERD patients. Currently, Somna Therapeutics is refining the Reza Band's design and conducting clinical trials to secure FDA clearance. Post-clearance, the company plans to sell its device to hospitals, clinics, and home healthcare providers.
HealthMyne
Series B in 2018
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative imaging solutions and analytics primarily for cancer care providers. The company's technology enhances clinical decision-making by offering real-time, evidence-based imaging insights that facilitate improved patient care while also reducing delivery costs. HealthMyne's platform includes features such as tumor image manipulation, automatic tumor staging, specialized reporting, and management of incidental findings, all aimed at streamlining clinical workflows. By integrating electronic health records and image repositories, HealthMyne supports physicians in diagnosing and treating patients more effectively, ultimately enhancing clinical collaboration and quality assurance in patient management.
Farcast Biosciences, established in 2019, is a clinical diagnostic company based in Boston, Massachusetts, with a lab in Bangalore, India. The company specializes in developing and utilizing a proprietary Human Tumor Micro Dynamics (HTMD) platform. This platform preserves the tumor microenvironment using fresh, unmodified human tumor fragments and autologous blood samples, enabling oncologists and drug developers to test individual tumors and predict patient response to treatments with higher accuracy. Farcast's mission is to illuminate personalized treatment paths for cancer patients by providing precise, patient-specific data.
HealthMyne
Venture Round in 2017
HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative imaging solutions and analytics primarily for cancer care providers. The company's technology enhances clinical decision-making by offering real-time, evidence-based imaging insights that facilitate improved patient care while also reducing delivery costs. HealthMyne's platform includes features such as tumor image manipulation, automatic tumor staging, specialized reporting, and management of incidental findings, all aimed at streamlining clinical workflows. By integrating electronic health records and image repositories, HealthMyne supports physicians in diagnosing and treating patients more effectively, ultimately enhancing clinical collaboration and quality assurance in patient management.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.